
Marking Progress, Promise of Prescription Digital Therapeutics for Mental Health: Interview with Shaheen Lakhan, MD, PhD
CLINICAL CONVERSATIONS The investigational prescription digital therapeutic (PDT), CT-155, codeveloped by Click Therapeutics and Boehringer Ingelheim (BI) for treatment of negative symptoms in schizophrenia is in phase 3 clinical testing, after receiving …